Literature DB >> 12437992

Can teatime increase one's lifetime?

Kei Nakachi1, Hidetaka Eguchi, Kazue Imai.   

Abstract

Lifestyle-related diseases, including cancer and cardiovascular disease, are also characterized as aging-related diseases, where aging may be the most potent causal factor. In light of this, prevention of lifestyle-related diseases will depend on slowing the aging process and avoiding the clinical appearance of the diseases. Green tea is now accepted as a cancer preventive on the basis of numerous in vitro, in vivo and epidemiological studies. In addition, green tea has also been reported to reduce the risk of cardiovascular disease. We found an apparent delay of cancer onset/death and all cause deaths associated with increased consumption of green tea, specifically in ages before 79 in a prospective cohort study of a Japanese population with 13-year follow-up data. This is consistent with analyses of age-specific cancer death rate and cumulative survival, indicating a significant slowing of the increase in cancer death and all cause death with aging. These results indicate that daily consumption of green tea in sufficient amounts will help to prolong life by avoiding pre-mature death, particularly death caused by cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12437992     DOI: 10.1016/s1568-1637(02)00047-8

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN: 1568-1637            Impact factor:   10.895


  13 in total

Review 1.  Tea and cognitive health in late life: current evidence and future directions.

Authors:  J Song; H Xu; F Liu; L Feng
Journal:  J Nutr Health Aging       Date:  2012-01       Impact factor: 4.075

2.  Cognitive function and tea consumption in community dwelling older Chinese in Singapore.

Authors:  L Feng; X Gwee; E-H Kua; T-P Ng
Journal:  J Nutr Health Aging       Date:  2010-06       Impact factor: 4.075

3.  Interaction Between the FOXO1A-209 Genotype and Tea Drinking Is Significantly Associated with Reduced Mortality at Advanced Ages.

Authors:  Yi Zeng; Huashuai Chen; Ting Ni; Rongping Ruan; Chao Nie; Xiaomin Liu; Lei Feng; Fengyu Zhang; Jiehua Lu; Jianxin Li; Yang Li; Wei Tao; Simon G Gregory; William Gottschalk; Michael W Lutz; Kenneth C Land; Anatoli Yashin; Qihua Tan; Ze Yang; Lars Bolund; Qi Ming; Huanming Yang; Junxia Min; D Craig Willcox; Bradley J Willcox; Jun Gu; Elizabeth Hauser; Xiao-Li Tian; James W Vaupel
Journal:  Rejuvenation Res       Date:  2016-02-10       Impact factor: 4.663

4.  Non-alcoholic beverage and caffeine consumption and mortality: the Leisure World Cohort Study.

Authors:  Annlia Paganini-Hill; Claudia H Kawas; María M Corrada
Journal:  Prev Med       Date:  2006-12-29       Impact factor: 4.018

5.  Effect of green tea (Camellia sinensis) consumption on the components of metabolic syndrome in elderly.

Authors:  A E Vieira Senger; C H A Schwanke; I Gomes; M G Valle Gottlieb
Journal:  J Nutr Health Aging       Date:  2012       Impact factor: 4.075

6.  Tea consumption and mortality in the oldest-old Chinese.

Authors:  Rongping Ruan; Lei Feng; Jialiang Li; Tze-Pin Ng; Yi Zeng
Journal:  J Am Geriatr Soc       Date:  2013-10-01       Impact factor: 5.562

7.  Cytoprotective propensity of green tea polyphenols against citrinin-induced skeletal-myotube damage in C2C12 cells.

Authors:  G R Sharath Babu; N Ilaiyaraja; Farhath Khanum; T Anand
Journal:  Cytotechnology       Date:  2017-05-23       Impact factor: 2.058

8.  Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG.

Authors:  Joel B Berletch; Canhui Liu; William K Love; Lucy G Andrews; Santosh K Katiyar; Trygve O Tollefsbol
Journal:  J Cell Biochem       Date:  2008-02-01       Impact factor: 4.429

Review 9.  Tea polyphenols for health promotion.

Authors:  Naghma Khan; Hasan Mukhtar
Journal:  Life Sci       Date:  2007-06-28       Impact factor: 5.037

Review 10.  Green tea (Camellia sinensis) for the prevention of cancer.

Authors:  Katja Boehm; Francesca Borrelli; Edzard Ernst; Gabi Habacher; Shao Kang Hung; Stefania Milazzo; Markus Horneber
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.